MARKET

OSTX

OSTX

OS THERAPIES INCORPORATED
AMEX
1.520
-0.040
-2.56%
After Hours: 1.557 +0.037 +2.44% 19:34 07/24 EDT
OPEN
1.560
PREV CLOSE
1.560
HIGH
1.560
LOW
1.500
VOLUME
240.71K
TURNOVER
--
52 WEEK HIGH
2.570
52 WEEK LOW
1.150
MARKET CAP
67.70M
P/E (TTM)
-1.4462
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at OSTX last week (0713-0717)?
Weekly Report · 5d ago
Weekly Report: what happened at OSTX last week (0706-0710)?
Weekly Report · 07/13 09:45
Roth MKM Initiates a Buy Rating on OS Therapies Incorporated (OSTX)
TipRanks · 07/10 09:15
OS Therapies Price Target Announced at $7.00/Share by Roth Capital
Dow Jones · 07/09 14:04
Roth Capital Initiates Coverage On OS Therapies with Buy Rating, Announces Price Target of $7
Benzinga · 07/09 13:54
OS Therapies initiated with a Buy at Roth Capital
TipRanks · 07/09 10:40
OS Therapies Accepts New FDA Meeting Request For Review Of Pharmacodynamic Response Biomarker Data
Benzinga · 07/08 13:08
OS Therapies Accepts New FDA Meeting Request to Review Biomarker Data as Part of BEST Program
Newsfile · 07/08 13:00
More
About OSTX
OS Therapies Incorporated is a clinical-stage oncology company focused on the identification, development, and commercialization of new class immunotherapy candidates for solid tumors, beginning with osteosarcoma and other solid tumors. Its pipeline includes two drug technologies: OST-HER2 and OST-tADC. Its lead asset, OST-HER2, is an off-the-shelf immunotherapy, which is a type of cancer treatment that helps one’s immune system fight cancer, comprised of a genetically weakened and modified strain of Listeria monocytogenes, a species of bacteria that causes the infection listeriosis, that expresses HER2 peptides. OST-tADC is a tunable ADC with a plug-and-play platform that features tunable pH-sensitive silicone linkers (SiLinkers). Its clinical-stage cancer immunotherapy programs also include OST-AXAL for human papilloma virus (HPV)-associated cancers; OST-503 for non-small cell lung cancer (NSCLC) & glioblastoma; and OST-PSA for prostate cancer.

Webull offers OS Therapies Inc stock information, including AMEX: OSTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OSTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OSTX stock methods without spending real money on the virtual paper trading platform.